Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation is a research paper published in Bioengineering & Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: T32AI095190
National Institute of General Medical Sciences
Grant: R35GM142752
National Institutes of Health
Grant: P30CA134274
NHLBI Division of Intramural Research
Grant: T32HL007698
NIH HHS
Grant: S10 OD030430
NCATS NIH HHS
Grant: UL1 TR003098
NIGMS NIH HHS
Grant: R25 GM055036
National Institutes of Health
Grant: 2P30CA134274-04
Protocol Specific Research
National Institutes of Health
Grant: 2T32AI095190-06
Signaling Pathways in Innate Immunity
National Institutes of Health
Grant: 5T32HL007698-20
Vascular Biology Training Program
National Institutes of Health
Grant: 5R35GM142752-03
Polymeric nanoassemblies for precise tuning of immune responses
Pharmaceutical Research and Manufacturers of America Foundation
National Cancer Institute
FWCI
0.84
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals